Fund HoldingsCheckpoint Capital L.P.

Total Portfolio Value
$182.27M
Total Bought
$51.60M
Total Sold
$60.70M
Net Transaction
-$9.11M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
ARGENX SE(ARGX)92,500115,000+22,50056,88868,06437.34%+11,177
SOLENO THERAPEUTICS INC70,027172,902+102,8753,14812,3546.78%+9,206
PROTAGONIST THERAPEUTICS INC0175,184+175,18408,4724.65%+8,472
RHYTHM PHARMACEUTICALS INC(RYTM)727,982907,240+179,25840,75248,05726.37%+7,304
SEPTERNA INC(SEPN)0824,878+824,87804,7762.62%+4,776
REVOLUTION MEDICINES INC(RVMD)210,000392,011+182,0119,18513,8627.61%+4,676
STOKE THERAPEUTICS INC(STOK)305,387730,717+425,3303,3684,8592.67%+1,491
KYMERA THERAPEUTICS INC(KYMR)77,535136,605+59,0703,1193,7392.05%+620
CORCEPT THERAPEUTICS INC(CORT)05,000+5,00005710.31%+571
DISC MEDICINE INC(IRON)185,000243,311+58,31111,72912,0786.63%+349
IMMUNOCORE HLDGS PLC(IMCR)09,011+9,01102670.15%+267
RAPT THERAPEUTICS INC0109,830+109,83001340.07%+134
CYTOKINETICS INC(CYTK)20,0000-20,0009410-941
ATYR PHARMA INC432,5610-432,5611,5660-1,566
TSCAN THERAPEUTICS INC1,755,9872,017,650+261,6635,3382,7841.53%-2,554
CIDARA THERAPEUTICS INC196,949104,380-92,5695,1142,2481.23%-2,865
TREVI THERAPEUTICS INC(TRVI)1,084,1350-1,084,1354,4670-4,467
PLIANT THERAPEUTICS INC535,4940-535,4947,0520-7,052
AVADEL PHARMACEUTICALS PLC1,004,7900-1,004,79010,5600-10,560
AXSOME THERAPEUTICS INC(AXSM)174,7690-174,76914,7870-14,787
PHATHOM PHARMACEUTICALS INC(PHAT)2,274,1570-2,274,15718,4660-18,466
Page 1 of 1